These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18714155)

  • 1. Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines.
    Namwat N; Amimanan P; Loilome W; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tassaneeyakul W
    Chemotherapy; 2008; 54(5):343-51. PubMed ID: 18714155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
    De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH
    Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
    De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
    Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.
    de Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; Reichelt W; Beigi M; Clausen OP; Galteland E; Stokke T
    Int J Oncol; 2004 May; 24(5):1279-88. PubMed ID: 15067352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors.
    Wang W; Marsh S; Cassidy J; McLeod HL
    Cancer Res; 2001 Jul; 61(14):5505-10. PubMed ID: 11454699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.
    Wang W; McLeod HL; Cassidy J; Collie-Duguid ES
    Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic and predictive profiling of 5-Fluorouracil resistance in human cancer cells.
    Wang W; Cassidy J; O'Brien V; Ryan KM; Collie-Duguid E
    Cancer Res; 2004 Nov; 64(22):8167-76. PubMed ID: 15548681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray.
    Park JS; Young Yoon S; Kim JM; Yeom YI; Kim YS; Kim NS
    Cancer Lett; 2004 Oct; 214(1):19-33. PubMed ID: 15331170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 10.  Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma.
    Sribenja S; Natthasirikul N; Vaeteewoottacharn K; Sawanyawisuth K; Wongkham C; Jearanaikoon P; Wongkham S
    Ann Hepatol; 2016; 15(4):577-85. PubMed ID: 27236157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK4 regulates 5-fluorouracil sensitivity in cholangiocarcinoma cells by modulating the intrinsic apoptosis pathway.
    Ge X; Wang Y; Li Q; Yu H; Ji G; Miao L
    Oncol Rep; 2013 Jul; 30(1):448-54. PubMed ID: 23619566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle perturbation and acquired 5-fluorouracil chemoresistance.
    Guo X; Goessl E; Jin G; Collie-Duguid ES; Cassidy J; Wang W; O'Brien V
    Anticancer Res; 2008; 28(1A):9-14. PubMed ID: 18383818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cells.
    Ju J; Schmitz JC; Song B; Kudo K; Chu E
    Clin Cancer Res; 2007 Jul; 13(14):4245-51. PubMed ID: 17634554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
    Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F
    Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics.
    Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Wongkham S
    Cancer; 2007 Jun; 109(12):2497-505. PubMed ID: 17487855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance.
    Intuyod K; Saavedra-García P; Zona S; Lai CF; Jiramongkol Y; Vaeteewoottacharn K; Pairojkul C; Yao S; Yong JS; Trakansuebkul S; Waraasawapati S; Luvira V; Wongkham S; Pinlaor S; Lam EW
    Cell Death Dis; 2018 Dec; 9(12):1185. PubMed ID: 30538221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase.
    Klinhom-On N; Seubwai W; Sawanyawisuth K; Obchoei S; Mahalapbutr P; Wongkham S
    Life Sci; 2021 Dec; 286():120072. PubMed ID: 34688691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the ∆133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells.
    Nutthasirikul N; Hahnvajanawong C; Techasen A; Limpaiboon T; Leelayuwat C; Chau-In S; Jearanaikoon P
    Int J Oncol; 2015 Dec; 47(6):2153-64. PubMed ID: 26459801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
    Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y
    Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between p53 status and 5-fluorouracil sensitivity in 3 cell lines.
    Oka H; Ikeda K; Yoshimura H; Ohuchida A; Honma M
    Mutat Res; 2006 Jul; 606(1-2):52-60. PubMed ID: 16584912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.